The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Eosinophil responses during COVID-19 infections and coronavirus vaccination
Open accessAbstract
Abstract Eosinophils are circulating and tissue-resident leukocytes that have potent pro-inflammatory effects in a number of diseases. Recently, eosinophils have been shown to have a variety of other functions, including immunoregulation and antiviral activity. Eosinophil levels vary dramatically in a number of clinical settings, especially following eosinophil-targeted therapy, which is now available to selectively deplete these cells. There are key COVID-19–related questions concerning eosinophils whose answers affect recommended prevention and care. First, do patients with eosinophilia-associated diseases have an altered course of COVID-19? Second, do patients with eosinopenia (now intentionally induced by biological drugs) have unique COVID-19 susceptibility and/or disease course? This is a particularly relevant question as eosinopenia is associated with acute respiratory deterioration during infection with the Severe Acute Respiratory Syndrome (SARS)-Corona Virus (CoV)-2, the causative agent of COVID-19. Third, do eosinophils contribute to the lung pathology induced during COVID-19 and will they contribute to immunopotentiation potentially associated with emerging COVID-19 vaccines? Herein, we address these timely questions and project considerations during the emerging COVID-19 pandemic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa248 · Cited by 4,775
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,219
KIM, H. W., CANCHOLA, J. G., BRANDT, C. D., PYLES, G., CHANOCK, R. M., JENSEN, K., & PARROTT, R. H. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120955 · Cited by 1,981
Tian, S., Hu, W., Niu, L., Liu, H., Xu, H., & Xiao, S.-Y. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.02.010 · Cited by 1,414
Bleecker, E. R., FitzGerald, J. M., Chanez, P., Papi, A., Weinstein, S. F., Barker, P., Sproule, S., Gilmartin, G., Aurivillius, M., Werkström, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31324-1 · Cited by 1,406
FitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
MERS, SARS and other coronaviruses as causes of pneumonia
Yin, Y., & Wunderink, R. G. (2018) · Respirology · doi:10.1111/resp.13196 · Cited by 1,095
KAPIKIAN, A. Z., MITCHELL, R. H., CHANOCK, R. M., SHVEDOFF, R. A., & STEWART, C. E. (1969) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120954 · Cited by 1,033
Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L., Wang, H. H. X., Luo, M., Chen, L., & Zhao, Y. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.002 · Cited by 1,033
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China
Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., Xiong, Y., Cheng, Z., Gao, S., Liang, K., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa270 · Cited by 853
COVID-19 Autopsies, Oklahoma, USA
Barton, L. M., Duval, E. J., Stroberg, E., Ghosh, S., & Mukhopadhyay, S. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa062 · Cited by 839
Rothenberg, M. E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805283382206 · Cited by 834
Self-citationJohnston, S. L., Pattemore, P. K., Sanderson, G., Smith, S., Campbell, M. J., Josephs, L. K., Cunningham, A., Robinson, B. S., Myint, S. H., Ward, M. E., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810601 · Cited by 565
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035421 · Cited by 561
The SARS-CoV-2 Vaccine Pipeline: an Overview
Chen, W.-H., Strych, U., Hotez, P. J., & Bottazzi, M. E. (2020) · Current Tropical Medicine Reports · doi:10.1007/s40475-020-00201-6 · Cited by 511
Functions of tissue-resident eosinophils
Weller, P. F., & Spencer, L. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.95 · Cited by 480
Bolles, M., Deming, D., Long, K., Agnihothram, S., Whitmore, A., Ferris, M., Funkhouser, W., Gralinski, L., Totura, A., Heise, M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06048-11 · Cited by 477
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Eosinophil Cytokines, Chemokines, and Growth Factors: Emerging Roles in Immunity
Davoine, F., & Lacy, P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00570 · Cited by 353
Liu, F., Xu, A., Zhang, Y., Xuan, W., Yan, T., Pan, K., Yu, W., & Zhang, J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.013 · Cited by 346
Weingartl, H., Czub, M., Czub, S., Neufeld, J., Marszal, P., Gren, J., Smith, G., Jones, S., Proulx, R., Deschambault, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12672-12676.2004 · Cited by 344
The September epidemic of asthma exacerbations in children: A search for etiology
Johnston, N. W., Johnston, S. L., Duncan, J. M., Greene, J. M., Kebadze, T., Keith, P. K., Roy, M., Waserman, S., & Sears, M. R. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.09.025 · Cited by 343
Prevalence of viral respiratory tract infections in children with asthma
Khetsuriani, N., Kazerouni, N. N., Erdman, D. D., Lu, X., Redd, S. C., Anderson, L. J., & Teague, W. G. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.041 · Cited by 316
Busse, W. W., Bleecker, E. R., FitzGerald, J. M., Ferguson, G. T., Barker, P., Sproule, S., Olsson, R. F., Martin, U. J., Goldman, M., Yañez, A., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30406-5 · Cited by 314
Nagase, H., Okugawa, S., Ota, Y., Yamaguchi, M., Tomizawa, H., Matsushima, K., Ohta, K., Yamamoto, K., & Hirai, K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.3977 · Cited by 305
Phipps, S., Lam, C. E., Mahalingam, S., Newhouse, M., Ramirez, R., Rosenberg, H. F., Foster, P. S., & Matthaei, K. I. (2007) · Blood · doi:10.1182/blood-2007-01-071340 · Cited by 305
Domachowske, J. B., Dyer, K. D., Bonville, C. A., & Rosenberg, H. F. (1998) · The Journal of Infectious Diseases · doi:10.1086/515322 · Cited by 293
Rosenberg, H. F., & Domachowske, J. B. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.5.691 · Cited by 286
Lugogo, N., Domingo, C., Chanez, P., Leigh, R., Gilson, M. J., Price, R. G., Yancey, S. W., & Ortega, H. G. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.07.010 · Cited by 283
Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., Pickles, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 275
Winthrop, K. L., Mariette, X., Silva, J. T., Benamu, E., Calabrese, L. H., Dumusc, A., Smolen, J. S., Aguado, J. M., & Fernández-Ruiz, M. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.02.002 · Cited by 259
Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6337 · Cited by 252
Edwards, M. R., Strong, K., Cameron, A., Walton, R. P., Jackson, D. J., & Johnston, S. L. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.025 · Cited by 212
Honda-Okubo, Y., Barnard, D., Ong, C. H., Peng, B.-H., Tseng, C.-T. K., & Petrovsky, N. (2015) · Journal of Virology · doi:10.1128/jvi.02980-14 · Cited by 210
Busse, W., Chupp, G., Nagase, H., Albers, F. C., Doyle, S., Shen, Q., Bratton, D. J., & Gunsoy, N. B. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.031 · Cited by 209
Domachowske, J. B., Dyer, K. D., Adams, A. G., Leto, T. L., & Rosenberg, H. F. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.14.3358 · Cited by 195
Du, L., Zhao, G., He, Y., Guo, Y., Zheng, B.-J., Jiang, S., & Zhou, Y. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.10.031 · Cited by 182
Intracellular Signaling Mechanisms Regulating Toll-Like Receptor–Mediated Activation of Eosinophils
Wong, C. K., Cheung, P. F. Y., Ip, W. K., & Lam, C. W. K. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0457oc · Cited by 177
Eosinophils Promote Antiviral Immunity in Mice Infected with Influenza A Virus
Samarasinghe, A. E., Melo, R. C. N., Duan, S., LeMessurier, K. S., Liedmann, S., Surman, S. L., Lee, J. J., Hurwitz, J. L., Thomas, P. G., & McCullers, J. A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600787 · Cited by 173
Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease
Castilow, E. M., Olson, M. R., & Varga, S. M. (2007) · Immunologic Research · doi:10.1007/s12026-007-0071-6 · Cited by 153
Antibody responses to individual proteins of SARS coronavirus and their neutralization activities
Qiu, M., Shi, Y., Guo, Z., Chen, Z., He, R., Chen, R., Zhou, D., Dai, E., Wang, X., Si, B., et al. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.02.006 · Cited by 147
Juhn, Y. J. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.04.024 · Cited by 142
Jiang, S., Bottazzi, M. E., Du, L., Lustigman, S., Tseng, C.-T. K., Curti, E., Jones, K. M., Zhan, B., & Hotez, P. J. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.126 · Cited by 137
Bass, D. (1975) · Journal of Clinical Investigation · doi:10.1172/jci108166 · Cited by 135
Iwata‐Yoshikawa, N., Uda, A., Suzuki, T., Tsunetsugu‐Yokota, Y., Sato, Y., Morikawa, S., Tashiro, M., Sata, T., Hasegawa, H., & Nagata, N. (2014) · Journal of Virology · doi:10.1128/jvi.00983-14 · Cited by 132
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492 · Cited by 122
Human and Mouse Eosinophils Have Antiviral Activity against Parainfluenza Virus
Drake, M. G., Bivins-Smith, E. R., Proskocil, B. J., Nie, Z., Scott, G. D., Lee, J. J., Lee, N. A., Fryer, A. D., & Jacoby, D. B. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0405oc · Cited by 122
del Pozo, V., de Andrés, B., Martín‐Orozco, E., Cárdaba, B., Fernández, J. C., Gallardo, S., Tramón, P., Palomino, P., Lahoz, C., & Leyva‐Cobián, F. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220736 · Cited by 120
Eosinophils Bind Rhinovirus and Activate Virus-Specific T Cells
Handzel, Z. T., Busse, W. W., Sedgwick, J. B., Vrtis, R. F., Lee, W. M., KELLY, E. A. B., & Gern, J. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1279 · Cited by 118
Biologics in chronic rhinosinusitis with nasal polyposis
Laidlaw, T. M., & Buchheit, K. M. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.12.001 · Cited by 115
Eosinophils and Respiratory Viruses
Flores-Torres, A. S., Salinas-Carmona, M. C., Salinas, E., & Rosas-Taraco, A. G. (2019) · Viral Immunology · doi:10.1089/vim.2018.0150 · Cited by 106
Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab
Jackson, D. J., Korn, S., Mathur, S. K., Barker, P. N., Meka, V. G., Martin, U. J., & Zangrilli, J. (2020) · Drug Safety · doi:10.1007/s40264-020-00926-3 · Cited by 93
Malinczak, C., Fonseca, W., Rasky, A. J., Ptaschinski, C., Morris, S. B., Ziegler, S. F., & Lukacs, N. W. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0171-3 · Cited by 91
Piñeros, Y. S. S., Bal, S. M., van de Pol, M. A., Dierdorp, B., Dekker, T., Dijkhuis, A., Brinkman, P., van der Sluijs, K., Zwinderman, A. H., Majoor, C. J., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201803-0461oc · Cited by 89
Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies
Katial, R. K., Bensch, G. W., Busse, W. W., Chipps, B. E., Denson, J. L., Gerber, A. N., Jacobs, J., Kraft, M., Martin, R. J., Nair, P. K., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.11.029 · Cited by 74
and the CREMS network, Lavoignet, C.-É., Borgne, P. L., Chabrier, S., Bidoire, J., Slimani, H., Chevrolet-Lavoignet, J., Lefèbvre, F., Jebri, R., Sengler, L., et al. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03583-2 · Cited by 67
Clay, C. C., Donart, N., Fomukong, N. G., Knight, J. B., Lei, W., Price, L., Hahn, F. F., Westrienen, J. V., & Harrod, K. S. (2012) · Journal of Virology · doi:10.1128/jvi.06791-11 · Cited by 64
Pediatric Hypereosinophilia: Characteristics, Clinical Manifestations, and Diagnoses
Burris, D. L., Rosenberg, C. E., Schwartz, J. T., Zhang, Y., Eby, M. D., Abonia, J. P., & Fulkerson, P. C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.05.011 · Cited by 49
Self-citationDu, L., Zhao, G., Chan, C. C. S., Li, L., He, Y., Zhou, Y., Zheng, B., & Jiang, S. (2010) · Viral Immunology · doi:10.1089/vim.2009.0090 · Cited by 46
Treatment of Hypereosinophilic Syndromes with Prednisone, Hydroxyurea, and Interferon
Butterfield, J. H. (2007) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2007.06.003 · Cited by 41
Bjerregaard, A., Laing, I. A., Backer, V., Sverrild, A., Khoo, S. K., Chidlow, G. R., Sikazwe, C. T., Smith, D. W., Souëf, P. N. L., & Porsbjerg, C. M. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12935 · Cited by 41
Su, Y.-C., Townsend, D., Herrero, L. J., Zaid, A., Rolph, M. S., Gahan, M. E., Nelson, M. A., Rudd, P. A., Matthaei, K. I., Foster, P. S., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01536-14 · Cited by 38
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
Yousefi, S., Sharma, S. K., Stojkov, D., Germič, N., Aeschlimann, S., Ge, M. Q., Flayer, C. H., Larson, E. D., Redai, I. G., Zhang, S., et al. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ab1117-455r · Cited by 36
Ishii, K., Hasegawa, H., Nagata, N., Ami, Y., Fukushi, S., Taguchi, F., & Tsunetsugu‐Yokota, Y. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00097.x · Cited by 20
Respiratory Syncytial Virus Vaccine Approaches: a Current Overview
Clark, C. M., & Guerrero-Plata, A. (2017) · Current Clinical Microbiology Reports · doi:10.1007/s40588-017-0074-6 · Cited by 17
Cited by
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Azkur, A. K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M., O’Mahony, L., Gao, Y., Nadeau, K., & Akdis, C. A. (2020) · Allergy · doi:10.1111/all.14364 · Cited by 1,119
Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 324
Hypereosinophilia causes progressive cardiac pathologies in mice
Diny, N. L., Wood, M. K., Won, T., Talor, M. V., Lukban, C., Bedja, D., Wang, N., Kalinoski, H., Daoud, A., Talbot, C. C., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107990 · Cited by 7
Understanding the Type 2 Immunity: An Evolving View Beyond Allergic Diseases
Jiménez‐Saiz, R., Iborra, S., Blanco, C., González‐Pérez, R., Nuñez‐Borque, E., Zeyneloglu, C., Babayev, H., Göksel, O., Göksel, T., Khaitov, M., et al. (2026) · Allergy · doi:10.1111/all.70512 · Cited by 2
Metadata
- Authors
- Lindsley, A. W., Schwartz, J. T., & Rothenberg, M. E.
- Venue
- Journal of Allergy and Clinical Immunology
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 146
- Issue
- 1
- Pages
- 1-7
- ISSN
- 0091-6749 (ISSN-L)
- OpenAlex
- W3018418935
- Cited by
- 354
- References
- 72
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.